Cargando…

Retrospective Long-Term Evaluation of Miltefosine-Allopurinol Treatment in Canine Leishmaniosis

Miltefosine-Allopurinol (MIL-AL) combination is reported to be one of the most effective treatments for canine leishmaniosis, thanks to its oral administration and MIL-documented low impact on renal function. However, MIL-AL is considered a second-choice treatment when compared to meglumine-antimoni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gizzarelli, Manuela, Foglia Manzillo, Valentina, Inglese, Antonio, Montagnaro, Serena, Oliva, Gaetano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384837/ https://www.ncbi.nlm.nih.gov/pubmed/37513711 http://dx.doi.org/10.3390/pathogens12070864

Ejemplares similares

Comparison of Two Dosing Regimens of Miltefosine, Both in Combination With Allopurinol, on Clinical and Parasitological Findings of Dogs With Leishmaniosis: A Pilot Study
por: Iarussi, Fabrizio, et al.
Publicado: (2020)

Clinical, Molecular and Serological Diagnosis of Canine Leishmaniosis: An Integrated Approach
por: Maurelli, Maria Paola, et al.
Publicado: (2020)

Serological and entomological survey of canine leishmaniasis in Lampedusa island, Italy
por: Foglia Manzillo, Valentina, et al.
Publicado: (2018)

Resolution of tongue lesions caused by Leishmania infantum in a dog treated with the association miltefosine-allopurinol
por: Foglia Manzillo, Valentina, et al.
Publicado: (2009)

Assessment of Circulating Immune Complexes During Natural and Experimental Canine Leishmaniasis
por: Gizzarelli, Manuela, et al.
Publicado: (2020)

Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol
por: Manna, Laura, et al.
Publicado: (2015)

Mapping the canine vector-borne disease risk in a Mediterranean area
por: Kostopoulou, Despoina, et al.
Publicado: (2020)

Meglumine Antimoniate and Miltefosine Combined With Allopurinol Sustain Pro-inflammatory Immune Environments During Canine Leishmaniosis Treatment
por: Santos, Marcos Ferreira, et al.
Publicado: (2019)

Clinical Significance of ROMs, OXY, SHp and HMGB-1 in Canine Leishmaniosis
por: Pugliese, Michela, et al.
Publicado: (2021)

Sternal Aspiration of Bone Marrow in Dogs: A Practical Approach for Canine Leishmaniasis Diagnosis and Monitoring
por: Paparcone, Rosa, et al.
Publicado: (2013)

Management of canine leishmaniosis in endemic SW European regions: a questionnaire-based multinational survey
por: Bourdeau, Patrick, et al.
Publicado: (2014)

LeishVet guidelines for the practical management of canine leishmaniosis
por: Solano-Gallego, Laia, et al.
Publicado: (2011)

Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol
por: Gonçalves, Gustavo, et al.
Publicado: (2021)

Prospective Study on the Incidence and Progression of Clinical Signs in Naïve Dogs Naturally Infected by Leishmania infantum
por: Foglia Manzillo, Valentina, et al.
Publicado: (2013)

Determination of the effect of collars containing 10% w/w imidacloprid and 4.5% w/w flumethrin (Seresto®) on the incidence of Leishmania and other canine vector-borne pathogen infections in Greece
por: Ligda, Panagiota, et al.
Publicado: (2023)

Canine leishmaniosis in South America
por: Dantas-Torres, Filipe
Publicado: (2009)

Proteinuria reduction after treatment with miltefosine and allopurinol in dogs naturally infected with leishmaniasis
por: Proverbio, Daniela, et al.
Publicado: (2016)

Clinical and Laboratory Response of Domiciled Dogs with Visceral Leishmaniasis Treated with Miltefosine and Allopurinol
por: Vaz, Talita Pereira, et al.
Publicado: (2023)

Simultaneous Detection of Parasitic Vector Borne Diseases: A Robust Cross-Sectional Survey in Hunting, Stray and Sheep Dogs in a Mediterranean Area
por: Gizzarelli, Manuela, et al.
Publicado: (2019)

A Questionnaire-Based Survey on the Long-Term Management of Canine Leishmaniosis by Veterinary Practitioners
por: Pereira, Maria A., et al.
Publicado: (2022)

Examining the Veterinary Electronic Antimicrobial Prescriptions for Dogs and Cats in the Campania Region, Italy: Corrective Strategies Are Imperative
por: Foglia Manzillo, Valentina, et al.
Publicado: (2023)

Successful treatment of feline leishmaniosis using a combination of allopurinol and N-methyl-glucamine antimoniate
por: Basso, Maria Alexandra, et al.
Publicado: (2016)

Renal dialysis and long-term treatment of a dog with kidney disease associated with canine leishmaniosis
por: Baneth, Gad, et al.
Publicado: (2018)

Atypical Lesions in Canine Leishmaniosis: Description of New Cases
por: Peris, María Paz, et al.
Publicado: (2022)

Survival time and prognostic factors in canine leishmaniosis in a non-endemic country treated with a two-phase protocol including initial allopurinol monotherapy
por: de Jong, Marja Klazina, et al.
Publicado: (2023)

Insights on adaptive and innate immunity in canine leishmaniosis
por: HOSEIN, SHAZIA, et al.
Publicado: (2017)

Prognostic Factors and Life Expectancy in Canine Leishmaniosis
por: Pereira, Maria Aires, et al.
Publicado: (2020)

Tongue nodules in canine leishmaniosis — a case report
por: Viegas, Carlos, et al.
Publicado: (2012)

Examining the Relationship of Clinical and Laboratory Parameters With Infectiousness to Phlebotomus perniciosus and Its Potential Infectivity in Dogs With Overt Clinical Leishmaniasis
por: Gizzarelli, Manuela, et al.
Publicado: (2021)

Canine leishmaniosis and its relationship to human visceral leishmaniasis in Eastern Uzbekistan
por: Kovalenko, Dmitriy A, et al.
Publicado: (2011)

LeishVet update and recommendations on feline leishmaniosis
por: Pennisi, Maria-Grazia, et al.
Publicado: (2015)

Canine leishmaniosis in Tunisia: Growing prevalence, larger zones of infection
por: Bouattour, Ali, et al.
Publicado: (2021)

Nutritional Modulation of the Immune Response Mediated by Nucleotides in Canine Leishmaniosis
por: Segarra, Sergi
Publicado: (2021)

Treatment and long-term follow-up of a cat with leishmaniosis
por: Brianti, Emanuele, et al.
Publicado: (2019)

Leishmaniosis
por: Pennisi, Maria Grazia
Publicado: (2019)

Seroepidemiology of canine leishmaniosis in Évora (southern Portugal): 20-year trends
por: Schallig, Henk DFH, et al.
Publicado: (2013)

Evaluation of various biomarkers for kidney monitoring during canine leishmaniosis treatment
por: Pardo-Marín, Luis, et al.
Publicado: (2017)

Epidemiologic, Clinical and Immunological Consequences of Co-Infections during Canine Leishmaniosis
por: Beasley, Erin A., et al.
Publicado: (2021)

Erythrocyte sedimentation rate in canine leishmaniosis diagnosis: A new resource
por: Cavalera, Maria Alfonsa, et al.
Publicado: (2022)

Evaluation of a Possible Synergistic Effect of Meglumine Antimoniate with Paromomycin, Miltefosine or Allopurinol on in Vitro Susceptibility of Leishmania tropica Resistant Isolate
por: REZAEI RIABI, Tahereh, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7eps0htuhesjeu2sst16tv1b7e